Invesco’s RSPH or iShares’ IBB: Which Healthcare ETF Is the Better Long-Term Buy?
Invesco S&P 500 Equal Weight Health Care ETF (NYSEMKT:RSPH) offers a broader, equal-weighted healthcare approach with lower historical volatility, while iShares Biotechnology ETF (NASDAQ:IBB) provides concentrated, market-cap-weighted exposure to the biotechnology industry.
Investors seeking healthcare exposure often choose between niche industry funds and broad-market strategies. While the Invesco fund tracks the wider S&P 500 healthcare universe with an equal-weighting methodology, the iShares fund focuses specifically on biotechnology, leading to different levels of concentration and risk.
Beta measures price volatility relative to the S&P 500; beta is calculated from monthly returns over the available fund history (up to five years). The 1-yr return represents total return over the trailing 12 months. Dividend yield is the trailing-12-month distribution yield.
Source: www.fool.com — article syndicated from the publisher’s feed; all rights remain with the original publisher.